Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.69 USD | +12.64% | +33.96% | +283.15% |
Jun. 10 | Lipocine Inc. Presents 52 Week Results from LPCN 1148 Phase 2 Study in Late-Breaking Session at EASL Congress 2024 | CI |
May. 09 | Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+283.15% | 57.17M | |
+16.42% | 122B | |
+19.02% | 113B | |
+3.52% | 22.66B | |
-11.63% | 16.68B | |
-16.50% | 16.61B | |
-39.57% | 16.92B | |
+2.68% | 13.62B | |
+21.16% | 11.04B | |
+108.78% | 10.43B |
- Stock Market
- Equities
- LPCN Stock
- News Lipocine Inc.
- Earnings Flash (LPCN) LIPOCINE Reports Q1 Revenue $7.6M